Previous close | 14.93 |
Open | 14.98 |
Bid | 14.91 x 100 |
Ask | 14.95 x 200 |
Day's range | 14.91 - 15.00 |
52-week range | 12.10 - 15.44 |
Volume | |
Avg. volume | 477,545 |
Market cap | 737.724M |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 9.38 |
EPS (TTM) | 1.59 |
Earnings date | 07 Aug 2024 |
Forward dividend & yield | 2.04 (13.66%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 15.56 |
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility. This significant investment, of which an initial $42.5 million was funded at closing, will be utilized to fuel the company's growth initiatives and expand its research and development efforts to further enhance its metabolomics platform.
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $60 million in growth capital to Metabolon, a global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications.
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $25 million in growth capital to Elevate K-12 ("Elevate"), a Chicago-based company that provides high-quality synchronous LIVE teaching for K-12 classrooms in the United States.